Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00IVN
|
|||
| Drug Name |
Navicixizumab
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1 | [1] | |
| Fallopian tube cancer [ICD-11: 2C74; ICD-10: C57.0] | Phase 1 | [2] | ||
| Metastatic colorectal cancer [ICD-11: 2B91; ICD-10: C19] | Phase 1 | [2] | ||
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1 | [1], [2] | ||
| Peritoneal cavity cancer [ICD-11: 2C51.Z] | Phase 1 | [2] | ||
| Company |
OncoMed Pharmaceuticals Redwood City, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.